Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease

Aspirin desensitization (AD) is an effective and safe therapeutic option for patients with nonsteroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (N-ERD). The mechanisms driving its beneficial effects remain poorly understood.

Source: Respiratory Medicine - April 29, 2019 Category: Respiratory Medicine Authors: Katarzyna Ewa Tyrak, Izabela Kupry ś-Lipińska, Ewa Czarnobilska, Bogdan Jakieła, Kinga Pajdzik, Adam Ćmiel, Hanna Plutecka, Mateusz Koziej, Aleksandra Gawrońska, Ewa Konduracka, Piotr Kuna, Marek Sanak, Lucyna Mastalerz Tags: Clinical Trial Paper Source Type: research